The Joint Corp. (JYNT) announced Christopher Grandpre has been elected as a director to help enable the company in achieving its goals of long-term growth in net new clinic openings, system-wide sales, comparable sales, and Adjusted EBITDA.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on JYNT:
- Joint Confirms Board Election and Key Approvals
- Cautious Hold Rating on The Joint Corp. Amid Strategic Transition and Market Uncertainty
- Joint Corp. Earnings Call: Mixed Sentiments and Strategic Shifts
- Joint Corp. price target lowered to $16 from $20 at Lake Street
- The Joint Corp. Reports Revenue Growth Amid Expansion